Eagle Health Investments
Latest statistics and disclosures from Eagle Health Investments's latest quarterly 13F-HR filing:
- Top 5 stock holdings are ARGX, INSM, NTRA, ICLR, ILMN, and represent 50.29% of Eagle Health Investments's stock portfolio.
- Added to shares of these 9 stocks: FTRE (+$8.3M), CMPS (+$5.4M), GH, SRRK, EXAS, CNTA, ALKS, RARE, PRCT.
- Started 4 new stock positions in FTRE, CNTA, CMPS, ALKS.
- Reduced shares in these 9 stocks: DXCM (-$24M), INSM (-$23M), , ALNY (-$10M), NBIX (-$7.6M), NTRA (-$5.2M), ICLR, AGIO, ILMN.
- Sold out of its positions in DXCM, UNH.
- Eagle Health Investments was a net seller of stock by $-66M.
- Eagle Health Investments has $381M in assets under management (AUM), dropping by -5.98%.
- Central Index Key (CIK): 0001842545
Tip: Access up to 7 years of quarterly data
Positions held by Eagle Health Investments consolidated in one spreadsheet with up to 7 years of data
Download as csvPortfolio Holdings for Eagle Health Investments
Eagle Health Investments holds 23 positions in its portfolio as reported in the September 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Argenx Se Sponsored Adr (ARGX) | 15.0 | $57M | 77k | 737.56 |
|
|
| Insmed Com Par $.01 (INSM) | 10.3 | $39M | -36% | 272k | 144.01 |
|
| Natera (NTRA) | 8.6 | $33M | -13% | 204k | 160.97 |
|
| Icon SHS (ICLR) | 8.4 | $32M | -9% | 183k | 175.00 |
|
| Illumina (ILMN) | 8.0 | $31M | -6% | 322k | 94.97 |
|
| Neurocrine Biosciences (NBIX) | 6.0 | $23M | -25% | 163k | 140.38 |
|
| Ultragenyx Pharmaceutical (RARE) | 5.5 | $21M | +11% | 697k | 30.08 |
|
| BioMarin Pharmaceutical (BMRN) | 5.2 | $20M | 367k | 54.16 |
|
|
| Guardant Health (GH) | 4.7 | $18M | +34% | 284k | 62.48 |
|
| EXACT Sciences Corporation (EXAS) | 3.9 | $15M | +21% | 271k | 54.71 |
|
| Scholar Rock Hldg Corp (SRRK) | 3.6 | $14M | +34% | 363k | 37.24 |
|
| Bridgebio Pharma (BBIO) | 3.5 | $14M | 259k | 51.94 |
|
|
| Procept Biorobotics Corp (PRCT) | 2.9 | $11M | +3% | 308k | 35.69 |
|
| Alnylam Pharmaceuticals (ALNY) | 2.8 | $11M | -48% | 24k | 456.00 |
|
| Akero Therapeutics (AKRO) | 2.8 | $11M | 226k | 47.48 |
|
|
| Agios Pharmaceuticals (AGIO) | 2.6 | $9.9M | -25% | 246k | 40.14 |
|
| Fortrea Hldgs Common Stock (FTRE) | 2.2 | $8.3M | NEW | 989k | 8.42 |
|
| Compass Pathways Sponsored Ads (CMPS) | 1.4 | $5.4M | NEW | 936k | 5.73 |
|
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 0.7 | $2.5M | NEW | 103k | 24.25 |
|
| Alkermes SHS (ALKS) | 0.6 | $2.5M | NEW | 82k | 30.00 |
|
| Intuitive Surgical Com New (ISRG) | 0.5 | $2.0M | 4.4k | 447.23 |
|
|
| Immunocore Hldgs Ads (IMCR) | 0.4 | $1.7M | 46k | 36.33 |
|
|
| Vir Biotechnology (VIR) | 0.4 | $1.4M | 241k | 5.71 |
|
Past Filings by Eagle Health Investments
SEC 13F filings are viewable for Eagle Health Investments going back to 2020
- Eagle Health Investments 2025 Q3 filed Nov. 7, 2025
- Eagle Health Investments 2025 Q2 filed Aug. 12, 2025
- Eagle Health Investments 2025 Q1 filed May 12, 2025
- Eagle Health Investments 2024 Q4 filed Feb. 12, 2025
- Eagle Health Investments 2024 Q3 filed Nov. 12, 2024
- Eagle Health Investments 2024 Q1 filed May 14, 2024
- Eagle Health Investments 2023 Q4 filed Feb. 12, 2024
- Eagle Health Investments 2023 Q3 filed Oct. 27, 2023
- Eagle Health Investments 2023 Q2 filed Aug. 14, 2023
- Eagle Health Investments 2023 Q1 filed May 12, 2023
- Eagle Health Investments 2022 Q4 filed Feb. 13, 2023
- Eagle Health Investments 2022 Q3 filed Nov. 14, 2022
- Eagle Health Investments 2022 Q2 filed Aug. 11, 2022
- Eagle Health Investments 2022 Q1 filed May 12, 2022
- Eagle Health Investments 2021 Q4 filed Feb. 10, 2022
- Eagle Health Investments 2021 Q3 filed Oct. 20, 2021